Brady Kevin M. 4

What Happened

• Kevin M. Brady, Chief Financial Officer & Treasurer of Medpace Holdings, exercised stock options on April 24, 2026, resulting in the acquisition of 7,000 shares at $138.87 each (total cost $972,090). The same filing shows the related derivative instrument for 7,000 shares was terminated (reported as disposed at $0.00) and awards totaling 15,000 restricted stock units (10,000 + 5,000 RSUs) were granted that day (reported at $0.00).

Key Details

• Transaction date: 2026-04-24.
• Option exercise: 7,000 shares acquired at $138.87 per share = $972,090 total.
• Derivative/option cancelled: 7,000 reported as disposed at $0.00 (reflects conversion/cancellation of the option instrument).
• Awards: 15,000 restricted stock units granted (10,000 and 5,000), reported at $0.00 (unvested).
• Shares owned after transaction: not specified in the information provided.
• Filing timeliness: Form filed 2026-04-28 for a 2026-04-24 transaction (filed within the SEC’s two-business-day Form 4 window).

Context

• The filing shows an exercise of vested options (footnote indicates at least one option vested in full on Feb 15, 2026). The derivative “disposed at $0.00” line reflects the option instrument being converted/cancelled upon exercise, not an open‑market sale of shares. The 15,000 RSUs are contingent rights to receive shares in the future and vest per the grant terms (footnotes state RSUs vest on the fifth anniversary of the grant, subject to continued employment). These awards are unvested and do not represent immediate liquidity.